BERKELEY HEIGHTS, N.J., Sept. 17 /PRNewswire-FirstCall/ -- Genta Inc. announced that the Food and Drug Administration (FDA) has allowed the Investigational New Drug (IND) exemption that was submitted by the Company for its new drug known as G4544.

BERKELEY HTS., N.J. and TARRYTOWN, N.Y., Aug. 1 /PRNewswire-FirstCall/ -- Genta Inc. and Emisphere Technologies, Inc. jointly announced today the submission of an Investigational New Drug Exemption (IND) to the Endocrinologic and Metabolic Drugs Division of the U.S.

WASHINGTON - A proposed leukemia drug should not receive federal approval, government advisers recommended Wednesday. Genasense is proposed to be given along with two other medications to patients with the most common adult form of the blood cancer, according to manufacturer Genta Inc.

By PAUL ELIAS Associated Press -- After years of disappointment, an elegantly simple medical technique that targets bad cells while leaving healthy ones alone could be making a comeback in the high-profile fights against cancer and the SARS virus.The technique, known as "antisense," aims to kill the genetic messenger carrying diseases.